104 related articles for article (PubMed ID: 20061812)
1. Gene therapy for acute myeloid leukemia using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Tan L; Xu B; Liu R; Liu H; Tan H; Huang W
Cancer Biol Ther; 2010 Mar; 9(5):350-7. PubMed ID: 20061812
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Zhang J; Frolov I; Russell SJ
J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
[TBL] [Abstract][Full Text] [Related]
4. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.
Galanis E; Bateman A; Johnson K; Diaz RM; James CD; Vile R; Russell SJ
Hum Gene Ther; 2001 May; 12(7):811-21. PubMed ID: 11339897
[TBL] [Abstract][Full Text] [Related]
5. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.
Fielding AK; Chapel-Fernandes S; Chadwick MP; Bullough FJ; Cosset FL; Russell SJ
Hum Gene Ther; 2000 Apr; 11(6):817-26. PubMed ID: 10779159
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effects of gene therapy with GALV membrane fusion glycoprotein in lung adenocarcinoma.
Zhu B; Yang JR; Fu XP; Jiang YQ
Cell Biochem Biophys; 2014 Jul; 69(3):577-82. PubMed ID: 24519667
[TBL] [Abstract][Full Text] [Related]
7. Construction of a replication-competent retroviral vector for expression of the VSV-G envelope glycoprotein for cancer gene therapy.
Jin SY; Jung YT
Arch Virol; 2020 May; 165(5):1089-1097. PubMed ID: 32146506
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy of lung adenocarcinoma using herpes virus expressing a fusogenic membrane glycoprotein.
Zhu B; Yang JR; Jiang YQ; Chen SF; Fu XP
Cell Biochem Biophys; 2014 Jul; 69(3):583-7. PubMed ID: 24510538
[TBL] [Abstract][Full Text] [Related]
9. Transduction of human hematopoietic progenitor cells with retroviral vectors based on the gibbon ape leukemia virus.
Eglitis MA; Schneiderman RD
Biochem Biophys Res Commun; 1997 Feb; 231(2):477-80. PubMed ID: 9070304
[TBL] [Abstract][Full Text] [Related]
10. Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect.
Fu X; Tao L; Jin A; Vile R; Brenner MK; Zhang X
Mol Ther; 2003 Jun; 7(6):748-54. PubMed ID: 12788648
[TBL] [Abstract][Full Text] [Related]
11. GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distribution.
Guedan S; Grases D; Rojas JJ; Gros A; Vilardell F; Vile R; Mercade E; Cascallo M; Alemany R
Gene Ther; 2012 Nov; 19(11):1048-57. PubMed ID: 22113313
[TBL] [Abstract][Full Text] [Related]
12. [The construction of recombinant type I herpes simplex virus carrying GALV.fus gene and its antitumor effect in nude mice].
Zhu M; Yang JR; Jiang YQ; Chen SF; Fu XP; Tian ZD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):152-6. PubMed ID: 21500543
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of retroviral vectors based on the gibbon ape leukemia virus.
Eglitis MA; Schneiderman RD; Rice PM; Eiden MV
Gene Ther; 1995 Sep; 2(7):486-92. PubMed ID: 7584127
[TBL] [Abstract][Full Text] [Related]
14. Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction.
Johnson KJ; Peng KW; Allen C; Russell SJ; Galanis E
Gene Ther; 2003 May; 10(9):725-32. PubMed ID: 12704411
[TBL] [Abstract][Full Text] [Related]
15. Fusion-defective gibbon ape leukemia virus vectors can be rescued by homologous but not heterologous soluble envelope proteins.
Farrell KB; Ting YT; Eiden MV
J Virol; 2002 May; 76(9):4267-74. PubMed ID: 11932392
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
[TBL] [Abstract][Full Text] [Related]
17. Gibbon ape leukemia virus poorly replicates in primary human T lymphocytes: implications for safety testing of primary human T lymphocytes transduced with GALV-pseudotyped vectors.
Lamers CH; Willemsen RA; van Elzakker PM; Gratama JW; Debets R
J Immunother; 2009 Apr; 32(3):272-9. PubMed ID: 19242373
[TBL] [Abstract][Full Text] [Related]
18. Active adenoviral vascular penetration by targeted formation of heterocellular endothelial-epithelial syncytia.
Chen HH; Cawood R; El-Sherbini Y; Purdie L; Bazan-Peregrino M; Seymour LW; Carlisle RC
Mol Ther; 2011 Jan; 19(1):67-75. PubMed ID: 20877345
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NF-kappaB in fusogenic membrane glycoprotein causing HL-60 cell death: implications for acute myeloid leukemia.
Tan L; Jia H; Liu R; Wu J; Han H; Zuo Y; Yang S; Huang W
Cancer Lett; 2009 Jan; 273(1):114-21. PubMed ID: 18783878
[TBL] [Abstract][Full Text] [Related]
20. Simian sarcoma-associated virus fails to infect Chinese hamster cells despite the presence of functional gibbon ape leukemia virus receptors.
Ting YT; Wilson CA; Farrell KB; Chaudry GJ; Eiden MV
J Virol; 1998 Dec; 72(12):9453-8. PubMed ID: 9811678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
